Targeted Treatment in Rheumatoid Arthritis

Dear Colleagues,

This Special Issue of Journal of Clinical Medicine (JCM), entitled "Targeted Treatment in Rheumatoid Arthritis", is dedicated to advancing our understanding of the latest developments in targeted treatment for this autoimmune disease. The aim of this Special Issue is to present innovative research and insights into new treatment targets and techniques for rheumatoid arthritis patients.

We would like to invite original research articles, reviews, and perspectives that focus on the development and utilization of targeted therapies to treat rheumatoid arthritis. However, we regret to inform the authors that we will not consider mini-reviews or case reports for this Special Issue.

Topics of interest include biological agents, small molecule inhibitors, immunomodulatory therapies, and personalized medicine approaches. We welcome submissions from researchers, practitioners, and scholars from around the world who are interested in improving patient outcomes for those with rheumatoid arthritis.

Overall, this Special Issue will provide an important platform for exchanging knowledge and exploring new therapeutic solutions for rheumatoid arthritis. We look forward to receiving your submissions and contributing towards advancements in targeted treatments for this condition.

Dr. Cinzia Rotondo
Dr. Simone Parisi
Dr. Simone Perniola
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.